ACE2 and COVID-19: Indeed, following the latter erroneous hypothesis, the gut would be the main target for COVID-19, as it expresses 70 times more ACE2 than the lungs (3 ▶), whereas intestinal symptoms are present in less than 15% of COVID-19 patients.